Testosterone, a hormone produced by women, is not currently recognized by the United States Food and Drug Administration (FDA) with any approved products for female use. This oversight highlights a broader issue in women's health where clinical experiences often outpace rigorous scientific study and funding. Dr. Komal Bajaj, Chief Medical Officer at Biote, discusses the historical impact of the Women's Health Initiative on hormone therapy perceptions and advocates for dedicated research and education to address the gap in understanding and treating women's hormonal health, particularly concerning testosterone's role in areas like sexual desire, bone density, and cardiovascular risk. AI
RANK_REASON Article discusses an under-addressed area of women's health and expert opinion on research and regulatory gaps, rather than a specific event.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
